发明名称 N-PHENYLARYLSULFONAMIDE COMPOUND, DRUG CONTAINING THE COMPOUND AS ACTIVE INGREDIENT, INTERMEDIATE FOR THE COMPOUND, AND PROCESSES FOR PRODUCING THE SAME
摘要 An N-phenylarylsulfonylamide compound represented by the general formula (I); an intermediate for the compound; and processes for producing these. The compound represented by the general formula (I) is bonded to a prostaglandin E2 receptor, especially an EP1 subtype receptor, to antagonize it, and has satisfactory in vivo activity because it is less affected by protein bonding. It is hence useful as an analgesic, antipyretic, remedy for frequent urination or lower urinary tract diseases, or carcinostatic substance. (I) In the formula, R<1> represents COOH, etc.; R<2> represents hydrogen, methyl, etc.; R<3> and R<4> represent a combination of methyl and methyl, etc.; R<5> represents isopropyl, etc.; Ar represents thiazolyl, pyridyl, or 5-methyl-2-furyl each optionally substituted by methyl; and n is 0 or 1.
申请公布号 WO02072564(A1) 申请公布日期 2002.09.19
申请号 WO2002JP02245 申请日期 2002.03.11
申请人 ONO PHARMACEUTICAL CO., LTD.;NAGANAWA, ATSUSHI;SAITOH, TETSUJI;KOBAYASHI, KAORU;MARUYAMA, TAKAYUKI;NAKAI, YOSHIHIKO;HASHIMOTO, SHINSUKE 发明人 NAGANAWA, ATSUSHI;SAITOH, TETSUJI;KOBAYASHI, KAORU;MARUYAMA, TAKAYUKI;NAKAI, YOSHIHIKO;HASHIMOTO, SHINSUKE
分类号 C07D307/64;A61K31/34;A61K31/341;A61K31/41;A61K31/4245;A61K31/426;A61K31/427;A61K31/4402;A61K31/4406;A61K31/4439;A61P1/04;A61P13/00;A61P13/02;A61P29/00;A61P35/00;A61P43/00;C07D213/70;C07D213/71;C07D277/20;C07D277/36;C07D401/12;C07D405/12;C07D413/12;C07D417/12;(IPC1-7):C07D307/64;A61K31/440;A61K31/443;A61K31/424 主分类号 C07D307/64
代理机构 代理人
主权项
地址